Northern Trust’s IVERIC bio ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-1,327,363
Closed -$52.2M – 4604
2023
Q2
$52.2M Buy
1,327,363
+24,641
+2% +$870K 0.01% 944
2023
Q1
$31.7M Buy
1,302,722
+38,920
+3% +$852K 0.01% 1246
2022
Q4
$27.1M Buy
1,263,802
+163,795
+15% +$3.5M 0.01% 1345
2022
Q3
$19.7M Buy
1,100,007
+14,964
+1% +$196K ﹤0.01% 1470
2022
Q2
$10.4M Buy
1,085,043
+29,926
+3% +$376K ﹤0.01% 2000
2022
Q1
$17.8M Sell
1,055,117
-42,484
-4% -$628K ﹤0.01% 1762
2021
Q4
$18.4M Buy
1,097,601
+124,791
+13% +$2.05M ﹤0.01% 1826
2021
Q3
$15.8M Buy
972,810
+109,918
+13% +$1.2M ﹤0.01% 1956
2021
Q2
$5.44M Buy
862,892
+47,200
+6% +$304K ﹤0.01% 2790
2021
Q1
$5.04M Sell
815,692
-50,816
-6% -$308K ﹤0.01% 2736
2020
Q4
$5.99M Sell
866,508
-2,016
-0.2% -$12.9K ﹤0.01% 2570
2020
Q3
$4.9M Buy
868,524
+361,965
+71% +$1.73M ﹤0.01% 2539
2020
Q2
$2.58M Buy
506,559
+434,230
+600% +$1.81M ﹤0.01% 2895
2020
Q1
$249K Buy
72,329
+7,481
+12% +$43.7K ﹤0.01% 3633
2019
Q4
$556K Sell
64,848
-22,181
-25% -$79.2K ﹤0.01% 3533
2019
Q3
$97K Hold
87,029
– – ﹤0.01% 3933
2019
Q2
$114K Buy
87,029
+93
+0.1% +$128 ﹤0.01% 3946
2019
Q1
$123K Sell
86,936
-93
-0.1% -$130 ﹤0.01% 3878
2018
Q4
$104K Buy
87,029
+12,594
+17% +$24.4K ﹤0.01% 3912
2018
Q3
$176K Sell
74,435
-17
-0% -$42 ﹤0.01% 3892
2018
Q2
$203K Hold
74,452
– – ﹤0.01% 3849
2018
Q1
$204K Buy
74,452
+21,330
+40% +$61.8K ﹤0.01% 3830
2017
Q4
$166K Hold
53,122
– – ﹤0.01% 3862
2017
Q3
$150K Sell
53,122
-12,982
-20% -$35.1K ﹤0.01% 3861
2017
Q2
$169K Sell
66,104
-283,635
-81% -$773K ﹤0.01% 3846
2017
Q1
$1.28M Buy
349,739
+9,444
+3% +$39.9K ﹤0.01% 3263
2016
Q4
$1.64M Buy
340,295
+1,519
+0.4% +$45.1K ﹤0.01% 3191
2016
Q3
$15.6M Buy
338,776
+2,341
+0.7% +$132K ﹤0.01% 1766
2016
Q2
$17.2M Buy
336,435
+63,224
+23% +$3.14M 0.01% 1643
2016
Q1
$11.5M Buy
273,211
+6,796
+3% +$346K ﹤0.01% 1870
2015
Q4
$20.9M Buy
266,415
+8,377
+3% +$484K 0.01% 1479
2015
Q3
$10.5M Buy
258,038
+103,019
+66% +$5.46M ﹤0.01% 1971
2015
Q2
$8.07M Buy
155,019
+10,708
+7% +$533K ﹤0.01% 2205
2015
Q1
$6.72M Buy
144,311
+1,961
+1% +$102K ﹤0.01% 2323
2014
Q4
$6.39M Sell
142,350
-4,870
-3% -$205K ﹤0.01% 2343
2014
Q3
$5.73M Buy
147,220
+23,151
+19% +$909K ﹤0.01% 2423
2014
Q2
$5.25M Buy
124,069
+10,770
+10% +$395K ﹤0.01% 2482
2014
Q1
$4.04M Sell
113,299
-6,021
-5% -$203K ﹤0.01% 2694
2013
Q4
$3.86M Buy
+119,320
New +$3.54M ﹤0.01% 2737

Northern Trust's ISEE Position: Q3 2023 in Review

Northern Trust sold out of IVERIC bio (ISEE) in Q3 2023, closing a stake of 1,327,363 shares — an estimated $52.2M sold.

Northern Trust first reported a position in ISEE in Q4 2013 and held it in 39 quarters. The position peaked at $52.2M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Northern Trust reported no remaining IVERIC bio position as of Q3 2023 after selling out during the quarter.
  • Northern Trust sold 1,327,363 IVERIC bio shares in Q3 2023, an estimated $52.2M.
  • Northern Trust first reported a position in IVERIC bio in Q4 2013 and held it in 39 quarters.
  • Northern Trust's IVERIC bio position peaked at $52.2M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio as of Q3 2023.

Based on Northern Trust's 13F filing for Q3 2023, filed 13 Nov 2023.